Sarah Blackstock
Critical Care Medicine · Marietta, GANPI 1598249211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,863 and has fallen 83.4% since, to $309 in 2025.
Across 176 payments — averaging $23.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$769
- Grifols USA, LLC$655
- AstraZeneca$619
- Regeneron Healthcare Solutions, Inc.$342
- AbbVie$235
- Amgen$190
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,187100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 40 | $769 |
| Grifols USA, LLC | 28 | $655 |
| AstraZeneca(2 entities) | 23 | $619 |
| Regeneron Healthcare Solutions, Inc. | 15 | $342 |
| AbbVie | 6 | $235 |
| Amgen | 5 | $190 |
| Boehringer Ingelheim | 7 | $158 |
| Mallinckrodt Hospital Products Inc. | 7 | $148 |
| Novo Nordisk | 1 | $125 |
| Abiomed | 1 | $119 |
| United Therapeutics Corporation | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| CSL Behring | 3 | $67 |
| Shionogi Inc | 3 | $63 |
| Baxter Healthcare | 3 | $60 |
| La Jolla Pharmaceutical Company | 3 | $57 |
| Sanofi | 2 | $55 |
| Mylan Specialty L.p. | 3 | $49 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| Pfizer | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Inogen, Inc. | 1 | $31 |
| Bayer | 2 | $30 |
| Boston Scientific | 1 | $29 |
| Gilead | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Lemaitre Vascular, Inc. | 1 | $12 |
| Exthera Medical Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,200 in reported general payments places this provider in the 85th percentile of 265 critical care medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Marietta
- Asif SaberiMarietta$5K
- Alexander GluzmanMarietta$4K
- Craig PattersonMarietta$4K
- Nikulkumar ChaudhariMarietta$2K
- Salman FidahusseinLagrange$852K
- Bruce FriedmanAugusta$629K
- Gregory MauldinSnellville$221K
- Ramzy RimawiAtlanta$72K
- Rafael Alba YunenBrunswick$58K
- April McDonaldGainesville$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.